Summary. New Zealand Obese (NZO) mice are eharaeterised by hyperglyeaemia, hyperinsulinaemia and obesity. The blood glucose and plasma insulin levels of these mice can be lowered to levels approaching those normally associated with non-obese mice, by the intraperitoneal implantation of pancreatic islets from albino mice which have had their fl-cells selectively destroyed by streptozotocin. Removal of these implanted islets causes the animals to revert to their original state. It would seem, therefore, that the genetic lesion responsible for the NZO state lies within the islets of Langerhans but not within the beta-cell. Its exact location is as yet unknown.
Islet Isolation and Implantation Procedure
Islets were isolated by a collagenase technique, sealed in diffusion chambers constructed from nylonreinforced Millipore membranes and implanted intraperitoneally as described elsewhere [1] .
Up to 3,000 islets could be collected in one day and 16 animals implanted. The usual number implanted in one day was 12.
The NZO mice were male, aged 5 to 8 weeks and separated into four groups, A, B, C and D. Follo~4ng initial weighing, blood was sampled from the clipped tail of each animal for glucose and insulin determination, after which each mouse received intraperitoneal implants of Millipore diffusion chambers containing either 200 islets isolated from normal albino mice (Group A), 200 similar islets but exposed to streptozotoein (Group B), chambers ~dth no tissue though treated with streptozotocin (Group C) or chambers with no tissue (Group D).
Streptozotocin Treatment of Islets
Approximately 200 islets were sealed in diffusion chambers and placed in a 300 mg~o solution of streptozotocin (Upjohn & Co.) pH 4.5 as described by Junod et al. [4] . The chambers were then agitated in a water bath maintained at 38~ for four minutes. Following this period of incubation, the chambers were transferred to Gey and Gey Ringer solution containing 30 rag% glucose and agitated for a further 20 min to remove residual traces of streptozotoein. Some chambers containing islets were subjected to the same procedure but in the absence of the cytotoxic agent (Group A).
Implant Removal
Implanted diffusion chambers were surgically removed from four animals of Group B and for a period of 6 weeks the body weight, blood glucose and plasma insulin levels were monitored.
Isolated Islet Function Tests
The functional activity of the islets both before and after implantation was examined by the sequential placing of the sealed chambers containing the islets in known volumes of Ringer solution containing the agents under study. Additionally, normal and streptozotocin-treated islets were tested, after a 6 week period of implantation, for their ability to synthesise proinsulin and insulin. Incorporation of 3tt-leucine into these hormones was determined by a modified method of Schatz et al. [5] . Following removal from the mice the chambers were incubated in the presence 402 I~. Gates et at. : Amelioration of NZO Mice of L-leucine-4,5-3I-I (50 txCi/ml, 30--50 Ci/mmole, New England Nuclear).
Body-Weight, Blood Glucose and Plasma Insulin
Determination All mice were weighed and blood samples taken from the tail at 0, 5, 15, 25, 35 and 45 days following implantation. Glucose was estimated by a modification of the Faulkner [6] method using a continous-flow analyser and plasma insulin by a double-antibody technique [7] using ox insulin as a standard.
Results

Minimum Number of Islets Necessary to Cause a
Reversion to the Non-obese State In order to find the minimum number of islets necessary to cause reversion, NZO mice were implanted with Millipore chambers containing 150, 100, 50 and 25 albino islets. Fig. 1 number necessary for complete reversion, 25 islets seem to cause partial reversion. Implantation with obese islets, pancreatic acinar tissue, liver and muscle showed that reversion was obtained only with implantation of albino islets thus eliminating both the exocrine pancreas and allergic reactions as being responsible for the return to normal.
Streptozotocin-Treatment of Isolated Islets
In order to verify that streptozotoein had inactivated the fl-cell of the pancreatic islets, Millipore chambers of Group B were incubated in alternate high and low concentrations of (a) glucose and (b) arginine (in the presence of 30 mg~o glucose). Table 1 shows that untreated islets release insulin appropriately when challenged with either arginine or glucose whereas streptozotocin-treated islets do not release insulin in amounts proportional to the secretagogue present. The pattern suggests a washing out of residual insulin following fl-cell destruction. After implantation, no insulin is released from the streptozotocin treated islets. Table 2 shows that islets maintain their integrity and function following 4 min incubation in a buffer at pH 4.5, but in the absence of streptozotocin. Fig. 3 (a) shows that after the implantation term, the islets exposed to streptozotocin do not incorporate SH-leucine into either insulin or proinsulin whereas Fig. 3 (b) shows that islets not exposed to streptozotocin and implanted for a similar period do incorporate aH-leucine into both these hormones. In addition when implanted chambers were removed from animals of Group B, macerated and then tested for insulin content, the total amount found in the original 200 islets was less than 15 ~U, which probably represents the concentrations of insulin present in physiological fluids. 25 untreated islets subjected to the same procedure gave an insulin content of 176 ~U. Thus, untreated islets contained approximately 100 times as much insulin as streptozotoein treated islets.
These findings show that both the secretory as well as the synthetic functions of the fl-cell have been destroyed by exposure to streptozotocin.
The results summarised in Figs. 4 to 6 are based on observations made on 38 animals that received implantation of Millipore diffusion chambers. Each point represents the arithmetic mean of group samples.
Body weight gains in the control groups (C and D)
period whereas the levels of Groups A and B showed a significant decrease compared to Groups C and D, Fig. 5 . The plasma insulin levels showed a trend similar to that of the blood glucose pattern. The levels in Groups A and B decreased significantly from those of the control groups (C and D) whose hyperinsulinaemia remained constant over the 45 days. Fig. 6 . 
Effect of Removal of Implanted Chambers on the Body
Weight, Blood Glucose and Plasma Insulin Diffusion chambers containing streptozotocin-treat. ed islets were surgically removed from four mice of Group B after the experimental term of 45 days. During the next six weeks, the animals reverted to the obese state with attendant hyperglycaemia and hyperinsulinaemia, Fig. 7 .
were greater than those found in animals having received implants containing either normal or streptozotocin-treated albino islets (Groups A and B), Fig. 4 .
There was no significant change in blood glucose in the control groups over the 45 day experimental
Discussion
When NZO mice are implanted intraperitoneally with Millipore diffusion chambers containing islets isolated from normal albino mice the hyperglycaemia and hyperinsulinaemia, associated with NZO mice, return to levels similar to that of non-obese mice [1] . This finding indicates that the genetic lesion responsible for the NZO state lies within the islets of Langerhans.
We have demonstrated that this effect is specific for normal islets in that NZO islets, acinar tissue, liver or muscle did not cause reversion. The minimum number of islets necessary for reversion to take place was found to be 50.
by the fact that the islets released no insulin following removal of the implant from the animal after 6 weeks. In addition, when implanted chambers were removed from the animal, macerated and then tested for insulin content only 15 ~U was found in 200 islets. This amount was 100 times less than that found in untreated islets. Streptozotocin-treated islets were unable to incorporate 3I-I-leucine into either proinsulin or insulin. 
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It has been shown that there are many cell types present in the islet. In addition to insulin, glucagon and gastrin secreting cells, a fourth cell type has recently been identified [8] . The functional significance of this cell is unknown. In order to narrow the field we investigated the effect of implanting streptozotocintreated islets. It was found that harvesting islets from streptozotocin-induced diabetic mice was difficult due to islet fragility. An in vitro technique was devised. This technique efficiently destroyed the //-cell as shown by the following evidence. The streptozotocintreated islets were unable to elicit the proper insulin response when placed sequentially in high and low concentrations of either arginine in 30 mg% glucose or glucose. Evidence of destruction was emphasized Streptozotocin-treated islets are thus capable of returning the weight gain, the blood glucose and plasma insulin of NZO mice to levels normally associated with albino mice. We conclude from this that insulin does not play a role in the reversion process.
These results are in agreement with those obtained by Strautz [2] using ob/ob mice. This suggests that the symptomatology exhibited by both NZO and ob/ob mice arises from the lack of the same substance or substances. We would suggest that there is more than one gene controlling the mechanisms necessary to produce and secrete this unknown substance and that the different hereditary characteristics shown by these two species are a reflection of the lesions.
More intriguing at the moment is the possible mode of action of this unknown substance/s. Mahler and Szabo [9] have shown that it is possible to get reversion of ob/ob characteristics by controlled treatment of suggest that the change in peripheral receptors could occur as a result of hyperinsulinaemia, reinforcing the previous suggestion that hypersecretion of insulin may be a primary fault. It has been shown that there is a close relationship between the functioning of e-and fl-cells in the islets [12] . It would seem logical to extend this finding and postulate that the missing There was no significant difference between Groups (C) and (D) the/?-cell with alloxan, and have suggested that hypersecretion of insulin is the primary lesion in these animals. Kahn et al. [10] and Baxter, Gates and Lazarus [11] have reported that there is a deficiency of insulin receptors in ob/ob and NZO mice respectively. Baxter, Gates and Lazarus [11] found that when NZO mice were reverted by implantation the number of insulin receptors in the liver increased until the number was identical to that found in white mice. However, the increase in receptors lagged well behind the decrease in both plasma insulin and blood glucose. These results factor in both NZ0 and ob/ob mice also plays a role in the normal integrated function of the islet. We suggest that one of the actions of this unknown substance is to regulate insulin secretion.
We speculate whether there may not exist in man an obese state that is due to a partial or total lack of this factor. The attendant hyperinsulinaemia would then produce a diminution in the number of insulin receptors with consequent dislocation of glucose metabolism and the appearance of all those symptoms associated with insulin resistance. 
